Exchange: OTC·Updated 09:49 AM EDT

PATLF Patrys Limited

$0.06
$0.01
(20.00%)
Today
Mkt Cap$40.49M
Vol20,000.00

About PATLF

Patrys Ltd. engages in the commercialization of the group's proprietary technologies to develop natural human antibody-based therapeutic products for the treatment of cancer and the pursuit of non-dilutive funding sources. Its pipeline includes PAT-DX1 antibody fragment, PAT-DX3 full sized antibody, and PAT-DX1-NP conjugated to nanoparticles. The company was founded by Daniel Devine on December 8, 2006 and is headquartered in South Melbourne, Australia.
50

Neutral Sentiment

How do you feel about PATLF?

Advertisement|Remove ads.